Mar 25, 2021

Aussie biotech Starpharma signs deal to sell COVID nose spray in Britain

Aussie biotech Starpharma signs deal to sell COVID nose spray in Britain

The Age reported Australian biotech Starpharma is taking its COVID-fighting antiviral nasal spray to the world, signing a deal with UK chemist chain LloydsPharmacy to sell the product in Britain as the country emerges from lockdown. Read more here

 This contains certain forward-looking statements.